Biologics Research Review, Issue 8

In this issue:

Tofacitinib for psoriatic arthritis
Serum trough level and anti-drug antibody of adalimumab
Switching from infliximab to the biosimilar CT-P13 in IBD
Long-term mucosal healing with vedolizumab
Continuation, tapering, and withdrawal of certolizumab pegol in RA
Bioassay for strength of tocilizumab IL-6/STAT3 signal inhibition
Patient-reported outcomes for baricitinib in RA
Certolizumab pegol and breast milk
Long-term outcomes of TNF inhibitor dose reduction in RA

Please login below to download this issue (PDF)

Subscribe